Calorie restriction or changes in dietary composition can enhance healthy aging, but the inability of most subjects to adhere to chronic and extreme diets, as well as potentially adverse effects, limits their application. We randomized 100 generally healthy participants from the United States into two study arms and tested the effects of a fasting-mimicking diet (FMD)-low in calories, sugars, and protein but high in unsaturated fats-on markers/risk factors associated with aging and age-related diseases. We compared subjects who followed 3 months of an unrestricted diet to subjects who consumed the FMD for 5 consecutive days per month for 3 months. Three FMD cycles reduced body weight, trunk, and total body fat; lowered blood pressure; and decreased insulin-like growth factor 1 (IGF-1). No serious adverse effects were reported. After 3 months, control diet subjects were crossed over to the FMD program, resulting in a total of 71 subjects completing three FMD cycles. A post hoc analysis of subjects from both FMD arms showed that body mass index, blood pressure, fasting glucose, IGF-1, triglycerides, total and low-density lipoprotein cholesterol, and C-reactive protein were more beneficially affected in participants at risk for disease than in subjects who were not at risk. Thus, cycles of a 5-day FMD are safe, feasible, and effective in reducing markers/risk factors for aging and age-related diseases. Larger studies in patients with diagnosed diseases or selected on the basis of risk factors are warranted to confirm the effect of the FMD on disease prevention and treatment.

Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease / Wei, M.; Brandhorst, S.; Mirzaei, H.; Cheng, C. W.; Shelehchi, M.; Budniak, J.; Groshen, S.; Guen, E.; Cohen, P.; Mather, M.; Zelinski, E.; Morgan, T. E.; Dorff, T.; Hong, K.; Laviano, A.; Longo, V. D.. - In: SCIENCE TRANSLATIONAL MEDICINE. - ISSN 1946-6242. - (2017). [10.1126/scitranslmed.aai8700]

Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease

Laviano A.
Penultimo
Writing – Review & Editing
;
2017

Abstract

Calorie restriction or changes in dietary composition can enhance healthy aging, but the inability of most subjects to adhere to chronic and extreme diets, as well as potentially adverse effects, limits their application. We randomized 100 generally healthy participants from the United States into two study arms and tested the effects of a fasting-mimicking diet (FMD)-low in calories, sugars, and protein but high in unsaturated fats-on markers/risk factors associated with aging and age-related diseases. We compared subjects who followed 3 months of an unrestricted diet to subjects who consumed the FMD for 5 consecutive days per month for 3 months. Three FMD cycles reduced body weight, trunk, and total body fat; lowered blood pressure; and decreased insulin-like growth factor 1 (IGF-1). No serious adverse effects were reported. After 3 months, control diet subjects were crossed over to the FMD program, resulting in a total of 71 subjects completing three FMD cycles. A post hoc analysis of subjects from both FMD arms showed that body mass index, blood pressure, fasting glucose, IGF-1, triglycerides, total and low-density lipoprotein cholesterol, and C-reactive protein were more beneficially affected in participants at risk for disease than in subjects who were not at risk. Thus, cycles of a 5-day FMD are safe, feasible, and effective in reducing markers/risk factors for aging and age-related diseases. Larger studies in patients with diagnosed diseases or selected on the basis of risk factors are warranted to confirm the effect of the FMD on disease prevention and treatment.
2017
Fating, fasting mimicking iet, cardiometabolic risk
01 Pubblicazione su rivista::01l Trial clinico
Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease / Wei, M.; Brandhorst, S.; Mirzaei, H.; Cheng, C. W.; Shelehchi, M.; Budniak, J.; Groshen, S.; Guen, E.; Cohen, P.; Mather, M.; Zelinski, E.; Morgan, T. E.; Dorff, T.; Hong, K.; Laviano, A.; Longo, V. D.. - In: SCIENCE TRANSLATIONAL MEDICINE. - ISSN 1946-6242. - (2017). [10.1126/scitranslmed.aai8700]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1652130
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 346
  • ???jsp.display-item.citation.isi??? 311
social impact